[1] European Society for Human Reproduction and Embryology (ESHRE) Guideline Group on POI,Webber L, Davies M, et al. ESHRE guideline: management of women with premature ovarian insufficiency[J]. Hum Reprod, 2016, 31(5): 926-937.
[2] 孙璐, 郑群, 范晓东,等. 早发性卵巢功能不全病因学及发病机制的研究进展[J]. 吉林大学学报(医学版), 2023(2): 1-8.
[3] 程姣姣, 阮祥燕, 冯欣, 等. 生育力保护保存与早发性卵巢功能不全的防治[J]. 临床药物治疗杂志, 2018, 16(3): 1-5.
[4] Chemaitilly W, Li Z, Krasin M J, et al. Premature ovarian insufficiency in childhood cancer survivors: a report from the St. Jude Lifetime Cohort[J]. J Clin Endocrinol Metab, 2017, 102(7): 2242-2250.
[5] Gargus E, Deans R, Anazodo A, et al. Management of primary ovarian insufficiency symptoms in survivors of childhood and adolescent cancer[J]. J Natl Compr Canc Netw, 2018, 16(9): 1137-1149.
[6] Levine J M, Whitton J A, Ginsberg J P, et al. Nonsurgical premature menopause and reproductive implications in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study: NSPM and reproductive implications[J]. Cancer, 2018, 124(5): 1044-1052.
[7] 徐文娟, 朱晓倩, 王建业, 等. 126例卵巢良性肿瘤术后卵巢储备功能正常患者行辅助生殖治疗的临床结局分析[J]. 安徽医科大学学报, 2022, 57(10): 1675-1679.
[8] 诸骏仁, 高润霖, 赵水平, 等. 中国成人血脂异常防治指南(2016年修订版)[J]. 中国循环杂志, 2016, 31(10): 937-953.
[9] Virani S S, Alonso A, Benjamin E J, et al. Heart disease and stroke statistics—2020 update: a report from the American Heart Association[J]. Circulation, 2020, 141(9): e139-e596.
[10]Ference B A, Ginsberg H N, Graham I, et al. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel[J]. Eur Heart J, 2017, 38(32): 2459-2472.
[11]中国心血管健康与疾病报告编写组.中国心血管健康与疾病报告2020概要[J]. 中国循环杂志, 2021, 36(6): 521-545.
[12]Lorenzo C, Delgado P, Busse C E, et al. ALDH4A1 is an atherosclerosis auto-antigen targeted by protective antibodies[J]. Nature, 2021, 589(7841): 287-292.
[13]Al-Aubaidy H A, Jelinek H F. Oxidative stress and triglycerides as predictors of subclinical atherosclerosis in prediabetes[J]. Redox Rep, 2014, 19(2): 87-91.
[14]Godsland I F. Effects of postmenopausal hormone replacement therapy on lipid, lipoprotein, and apolipoprotein (a) concentrations: analysis of studies published from 1974-2000[J]. Fertil Steril, 2001, 75(5): 898-915.
[15]田玉, 郑婷萍. 绝经后补充雌激素对女性血脂代谢的影响机制[J]. 实用妇产科杂志, 2018, 34(11): 826-829.
[16]Hamoda H, Panay N, Pedder H, et al. The British Menopause Society & Womens Health Concern 2020 recommendations on hormone replacement therapy in menopausal women[J]. Post Reprod Health, 2020, 26(4): 181-209.
[17]Ruan X. Chinese Society of Gynecological Endocrinology affiliated to the International Society of Gynecological Endocrinology Guideline for Ovarian Tissue Cryopreservation and Transplantation[J]. Gynecol Endocrinol, 2018, 34(12): 1005-1010.
[18]Ruan X, Cheng J, Korell M, et al. Ovarian tissue cryopreservation and transplantation prevents iatrogenic premature ovarian insufficiency: first 10 cases in China[J]. Climacteric, 2020, 23(6): 574-580.
[19]Ruan X, Du J, Lu D, et al. First pregnancy in China after ovarian tissue transplantation to prevent premature ovarian insufficiency[J]. Climacteric, 2021, 24(6): 624-628.
[20]Ruan X, Du J, Lu D, et al. First live birth in China after cryopreserved ovarian tissue transplantation to prevent premature ovarian insufficiency[J]. Climacteric, 2022, 25(4): 421-424.
[21]Czyzyk A, Filipowicz D, Podfigurna A, et al. Brain-derived neurotrophic factor (BDNF) plasma concentration in patients diagnosed with premature ovarian insufficiency (POI)[J]. Gynecol Endocrinol, 2017, 33(5): 413-417.
[22]Ates S, Yesil G, Sevket O, et al. Comparison of metabolic profile and abdominal fat distribution between karyotypically normal women with premature ovarian insufficiency and age matched controls[J]. Maturitas, 2014, 79(3): 306-310.
[23]Cekici Y, Kilic S, Ovayolu A, et al. Prediction of lipoprotein-associated phospholipase A2 and inflammatory markers in subclinical atherosclerosis in premature ovarian failure patients[J]. Acta Cardiol Sin, 2021, 37(1): 30-37.
[24]Gulhan I, Bozkaya G, Uyar I, et al. Serum lipid levels in women with premature ovarian failure[J]. Menopause, 2012, 19(11): 1231-1234.
[25]Huang Y, Lv Y, Qi T, et al. Metabolic profile of women with premature ovarian insufficiency compared with that of age-matched healthy controls[J]. Maturitas, 2021, 148: 33-39.
[26]Kulaksizoglu M, Ipekci S H, Kebapcilar L, et al. Risk factors for diabetes mellitus in women with primary ovarian insufficiency[J]. Biol Trace Elem Res, 2013, 154(3): 313-320.
[27]Podfigurna A, Stellmach A, Szeliga A, et al. Metabolic profile of patients with premature ovarian insufficiency[J]. J Clin Med, 2018, 7(10): 374.
|